An Innovative Canadian Pharmaceutical Company

Revenue Projected at $150,000,000 by 2025

Sponsored
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Is Engaged In High-Level Business Development

AGORACOM-KE
Mar 11, 2022 06:35PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Reports Record Annual Revenues For Fiscal 2021

AGORACOM-KE
Mar 11, 2022 10:27AM
Icon agoracom VIDEO - Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Hits Record Annual Revenues Of $13.6 MILLION … Targeting $150 MILLION By 2025

AGORACOM-KE
Mar 06, 2022 07:33PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

AGORACOM
Mar 03, 2022 05:31PM
Icon agoracom VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL 2021

AGORACOM-KE
Feb 28, 2022 08:47PM
Icon agoracom Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Ontario, Manitoba And New Brunswick

AGORACOM-KE
Feb 24, 2022 08:34AM
Icon agoracom VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2021 RESULTS CONFERENCE CALL / WEBCAST

AGORACOM-KE
Feb 21, 2022 07:00AM
Icon agoracom AGORACOM SmalCap 60: Valeo Pharma Aims To Build a First-Rate Top-Tier Canadian Company

AGORACOM-KE
Feb 04, 2022 05:43PM
Icon agoracom AGORACOM Small Cap 60: Are More Nationwide Retailers Coming For Valeo Pharma Immune Booster

AGORACOM-KE
Feb 04, 2022 11:41AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma is very encouraged by immune booster

AGORACOM-KE
Jan 28, 2022 10:17AM
Icon agoracom AGORACOM Small Cap 60: Main Ingredient of Valeo Pharma’s Immune Booster Has Been Well Documented In Numerous Scientific Publications

AGORACOM
Jan 20, 2022 02:14PM
Icon agoracom AGORACOM Small Cap 60: Clinical study of Valeo Immune Booster Yields Encouraging Results, May Help Reduce COVID-19 Associated Symptoms

AGORACOM
Jan 18, 2022 10:58AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Immune booster now available in 300 stores under Loblaws banners

AGORACOM-KE
Jan 14, 2022 04:16PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Commercializes Drugs from other Parts of the World

AGORACOM-KE
Jan 12, 2022 04:31PM
Icon agoracom VIDEO – Valeo Pharma Immune Booster Now Available In ~300 Stores Under Loblaws Banner, Another Step Closer to 2025 Revenue Target of $160M

AGORACOM
Jan 06, 2022 08:25AM
Icon agoracom Valeo Pharma's Hesperco™ Now Available At Loblaws, Hesperidin Covid-19 Clinical Trial Results Submitted For Publication

AGORACOM-KE
Jan 05, 2022 07:00AM
Icon agoracom VIDEO – Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Quebec and Nova Scotia, Another Step Closer to 2025 Revenue Target of $160M

AGORACOM
Dec 17, 2021 04:28PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

AGORACOM-KE
Dec 17, 2021 01:49PM
Icon agoracom Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Quebec And Nova Scotia

AGORACOM-KE
Dec 15, 2021 07:00AM
Icon agoracom Valeo Pharma Closes Previously Announced Upsized $15 Million Bought Deal Private Placement And Concurrent $10 Million Private Placement...

AGORACOM-KE
Dec 09, 2021 02:51PM
New Message